Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1980 1
1981 3
1983 2
1984 3
1985 2
1986 4
1987 4
1988 3
1989 7
1990 8
1991 4
1993 1
1994 6
1995 4
1996 2
1997 9
1998 15
1999 13
2000 15
2001 18
2002 30
2003 36
2004 22
2005 27
2006 43
2007 57
2008 61
2009 100
2010 99
2011 115
2012 130
2013 171
2014 206
2015 219
2016 202
2017 245
2018 249
2019 242
2020 286
2021 332
2022 299
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

2,936 results
Results by year
Filters applied: . Clear all
Page 1
Influenza and COVID-19: What does co-existence mean?
Chotpitayasunondh T, Fischer TK, Heraud JM, Hurt AC, Monto AS, Osterhaus A, Shu Y, Tam JS. Chotpitayasunondh T, et al. Among authors: shu y. Influenza Other Respir Viruses. 2021 May;15(3):407-412. doi: 10.1111/irv.12824. Epub 2020 Oct 31. Influenza Other Respir Viruses. 2021. PMID: 33128444 Free PMC article. Review.
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment.
Xu X, Liu C, Wang Y, Koivisto O, Zhou J, Shu Y, Zhang H. Xu X, et al. Among authors: shu y. Adv Drug Deliv Rev. 2021 Sep;176:113891. doi: 10.1016/j.addr.2021.113891. Epub 2021 Jul 26. Adv Drug Deliv Rev. 2021. PMID: 34324887 Free article. Review.
Characterizing dedifferentiation of thyroid cancer by integrated analysis.
Luo H, Xia X, Kim GD, Liu Y, Xue Z, Zhang L, Shu Y, Yang T, Chen Y, Zhang S, Chen H, Zhang W, Li R, Tang H, Dong B, Fu X, Cheng W, Zhang W, Yang L, Peng Y, Dai L, Hu H, Jiang Y, Gong C, Hu Y, Zhu J, Li Z, Caulin C, Wei T, Park J, Xu H. Luo H, et al. Among authors: shu y. Sci Adv. 2021 Jul 28;7(31):eabf3657. doi: 10.1126/sciadv.abf3657. Print 2021 Jul. Sci Adv. 2021. PMID: 34321197 Free PMC article.
Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.
Tuo QZ, Liu Y, Xiang Z, Yan HF, Zou T, Shu Y, Ding XL, Zou JJ, Xu S, Tang F, Gong YQ, Li XL, Guo YJ, Zheng ZY, Deng AP, Yang ZZ, Li WJ, Zhang ST, Ayton S, Bush AI, Xu H, Dai L, Dong B, Lei P. Tuo QZ, et al. Among authors: shu y. Signal Transduct Target Ther. 2022 Feb 23;7(1):59. doi: 10.1038/s41392-022-00917-z. Signal Transduct Target Ther. 2022. PMID: 35197442 Free PMC article.
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.
Ding Z, Li Q, Zhang R, Xie L, Shu Y, Gao S, Wang P, Su X, Qin Y, Wang Y, Fang J, Zhu Z, Xia X, Wei G, Wang H, Qian H, Guo X, Gao Z, Wang Y, Wei Y, Xu Q, Xu H, Yang L. Ding Z, et al. Among authors: shu y. Signal Transduct Target Ther. 2021 Jan 20;6(1):26. doi: 10.1038/s41392-020-00448-5. Signal Transduct Target Ther. 2021. PMID: 33473101 Free PMC article. Clinical Trial.
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Zhang T, Shi W, Zou J; CameL Study Group. Zhou C, et al. Among authors: shu y. Lancet Respir Med. 2021 Mar;9(3):305-314. doi: 10.1016/S2213-2600(20)30365-9. Epub 2020 Dec 18. Lancet Respir Med. 2021. PMID: 33347829 Clinical Trial.
2,936 results